Characteristics of outpatients with COPD in daily practice: The E4 Spanish project

Respiratory Medicine

Volumn 100, Issue 12, 2006, Pages 2137-2143

  Viejo Bañuelos, José L ^a   Pueyo Bastida, Ana ^a   Fueyo Rodríguez, Arturo ^b  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^b GLAXOSMITHKLINE   (Spain)

Author keywords

Airflow limitation; Chronic obstructive pulmonary disease (COPD); Cigarette smoking; COPD management; Primary care

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; CONSULTATION; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DISEASE SEVERITY; ELECTRONICS; FEMALE; FORCED EXPIRATORY VOLUME; FREQUENCY ANALYSIS; FUNCTIONAL DISEASE; GENDER BIAS; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SPAIN; STAGING;

ADMINISTRATION, INHALATION; AGED; AMBULATORY CARE; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; SMOKING CESSATION; SPAIN; STEROIDS;

EID: 33750891146     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.03.043     Document Type: Article

References (25)

1. WHO. World Health Report. Available at URL: http://www.who.int/whr/2002; 2002 [accessed 11.03.05].
2. Pauwels R.A., and Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364 (2004) 613-620
3. Weiss S.T., DeMeo D.L., and Postma D.S. COPD: problems in diagnosis and measurement. Eur Respir J 21 Suppl 41 (2003) 4s-12s
4. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
5. Rennard S., Decramer M., Calverley P.M., Pride N.B., Soriano J.B., Vermeire P.A., et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 20 (2002) 799-805
6. Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 97 Suppl C (2003) S3-S14
7. Dahl R., and Lofdahl C.G. The economic impact of COPD in North America and Europe. Analysis of the Confronting COPD survey. Introduction. Respir Med 97 Suppl C (2003) S1-S2
8. Halpern M.T., Musin A., and Sondhi S. Economic analysis of the Confronting COPD survey: methodology. Respir Med 97 Suppl C (2003) S15-S22
9. Izquierdo J.L. The burden of COPD in Spain: results from the Confronting COPD survey. Respir Med 97 Suppl C (2003) S61-S69
10. Siafakas N.M., Vermeire N.B., Pride P., Paoletti P., Gibson J., Howard P., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society (ERS). Eur Respir J 8 (1995) 1398-1420
11. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
12. Rodríguez Pascual L., Cordero Guevara J., and Viejo Bañuelos J.L. Estudio de la concordancia de dos aparatos para la medida del PEF y FEV1: neumotacógrafo versus PIKO 1 [Article in Spanish]. Arch Bronconeumol 42 3 (2006) 141-144
13. Thomas M., and Levy M.L. COPD management in the community: early detection and proactive care. Primary Care Respir J 14 (2005) 5-7
14. Barnes P.J., and Kleinert S. COPD-a neglected disease. Lancet 364 (2004) 613-620
15. Van den Boom G., Rutten-van Molken M.P., Tirimanna P.R., van Schayck C.P., Folgering H., and van Weel C. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 11 (1998) 67-72
16. Marco Jordan L., Martin Berra J.C., Corres Inigo M., Luque Diez R., and Zubillaga Garmendia G. Chronic obstructive lung disease in the general population. An epidemiologic study performed in Guipuzcoa. [Article in Spanish]. Arch Bronconeumol 34 (1998) 23-27
17. Miravitlles M., Murio C., Guerrero T., and Segu J.L. Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care [Article in Spanish]. Arch Bronconeumol 35 (1998) 173-178
18. Sobradillo Peña V.S., Miravitlles M., Gabriel R., Jimenez-Ruiz C.A., Villasante C., Masa J.F., et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 118 (2000) 981-989
19. Varkey A.B. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 10 (2004) 98-103
20. Chapman K.R. Chronic obstructive pulmonary disease: are women more susceptible than men?. Clin Chest Med 25 (2004) 331-341
21. Soriano J.B., Maier W.C., Egger P., Visick G., Thakrar B., Sykes J., et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 55 (2000) 789-794
22. Burney P., Suissa S., Soriano J.B., Vollmer W.M., Viegi G., Sullivan S.D., et al. The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J 22 Suppl 43 (2003) 1s-44s
23. Mannino D.M. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care 48 (2003) 1185-1193
24. Zielinski J., and Bednarek M. Know the age of your lung study group. Early detection of COPD in a high-risk population using spirometric screening. Chest 119 (2001) 731-736
25. Czajkowska-Malinowska M., Nowinski A., Gorecka D., and Zielinski J. Effects of spirometric screening in the community on smoking cessation. Pneumonol Alergol Pol 69 (2001) 524-529